1. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment;Chiodini, P.; Liuzzi, A.; Cozzi, R.;J Clin Endocrinol Metab,1981
2. A comparison of the endocrine profiles and clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia;Grossman, A.; Bouloux, P.; Loneragan, R.; tees LH; Wass, J.A.H.; Besser, G.M.;Clin Endoctinol,1985
3. Intolerance of bromocriptine: is metergoline a satisfactory alternative?;Casson, I.F.; Walker, B.A.; Hipkin, U.J.; Belchetz, P.E.;BrMedJ,1985
4. Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride;Graf, K.J.; Horowski, R.; Dorow, R.;Acta Endocrinol,1986
5. Jakobson 5, Akcerstrom G, Ljunghail S. Survival and renal function in untreated hypeccalcaemia;Palmer, M.; Adamin, H.; Bergstrom, R.;Lancet,1987